78 related articles for article (PubMed ID: 15833944)
1. Insulin and endothelin in the acute regulation of adiponectin in vivo in humans.
Brame LA; Considine RV; Yamauchi M; Baron AD; Mather KJ
Obes Res; 2005 Mar; 13(3):582-8. PubMed ID: 15833944
[TBL] [Abstract][Full Text] [Related]
2. Endothelin limits insulin action in obese/insulin-resistant humans.
Lteif A; Vaishnava P; Baron AD; Mather KJ
Diabetes; 2007 Mar; 56(3):728-34. PubMed ID: 17327443
[TBL] [Abstract][Full Text] [Related]
3. Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease.
Ahlborg G; Shemyakin A; Böhm F; Gonon A; Pernow J
Diabetes Care; 2007 Mar; 30(3):591-6. PubMed ID: 17327326
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
Ferri C; Carlomagno A; Coassin S; Baldoncini R; Cassone Faldetta MR; Laurenti O; Properzi G; Santucci A; De Mattia G
Diabetes Care; 1995 Feb; 18(2):226-33. PubMed ID: 7729302
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous ET-1 in the regulation of myocardial blood flow in lean and obese humans.
Mather KJ; Lteif AA; Veeneman E; Fain R; Giger S; Perry K; Hutchins GD
Obesity (Silver Spring); 2010 Jan; 18(1):63-70. PubMed ID: 19543207
[TBL] [Abstract][Full Text] [Related]
6. Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.
Lteif AA; Fulford AD; Considine RV; Gelfand I; Baron AD; Mather KJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1510-7. PubMed ID: 18957616
[TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin increases postprandially in obese, but not in lean, subjects.
English PJ; Coughlin SR; Hayden K; Malik IA; Wilding JP
Obes Res; 2003 Jul; 11(7):839-44. PubMed ID: 12855752
[TBL] [Abstract][Full Text] [Related]
8. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.
Mather KJ; Lteif A; Steinberg HO; Baron AD
Diabetes; 2004 Aug; 53(8):2060-6. PubMed ID: 15277386
[TBL] [Abstract][Full Text] [Related]
9. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.
Mather KJ; Mirzamohammadi B; Lteif A; Steinberg HO; Baron AD
Diabetes; 2002 Dec; 51(12):3517-23. PubMed ID: 12453909
[TBL] [Abstract][Full Text] [Related]
10. Serum adiponectin concentrations during a 72-hour fast in over- and normal-weight humans.
Merl V; Peters A; Oltmanns KM; Kern W; Born J; Fehm HL; Schultes B
Int J Obes (Lond); 2005 Aug; 29(8):998-1001. PubMed ID: 15917861
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox.
Dullaart RP; Riemens SC; Meinardi JR; Wolffenbuttel BH; Sluiter WJ
Scand J Clin Lab Invest; 2005; 65(6):523-31. PubMed ID: 16179286
[TBL] [Abstract][Full Text] [Related]
12. Specific endothelin ET(A) receptor antagonism does not modulate insulin-induced hemodynamic effects in the human kidney, eye, or forearm.
Rab A; Dallinger S; Polak K; Pleiner J; Polska E; Wolzt M; Schmetterer L
J Pharmacol Exp Ther; 2004 May; 309(2):692-6. PubMed ID: 14757848
[TBL] [Abstract][Full Text] [Related]
13. Insulin decreases human adiponectin plasma levels.
Möhlig M; Wegewitz U; Osterhoff M; Isken F; Ristow M; Pfeiffer AF; Spranger J
Horm Metab Res; 2002; 34(11-12):655-8. PubMed ID: 12660877
[TBL] [Abstract][Full Text] [Related]
14. Acute hyperinsulinemia differentially regulates interstitial and circulating adiponectin oligomeric pattern in lean and insulin-resistant, obese individuals.
Murdolo G; Hammarstedt A; Schmelz M; Jansson PA; Smith U
J Clin Endocrinol Metab; 2009 Nov; 94(11):4508-16. PubMed ID: 19820029
[TBL] [Abstract][Full Text] [Related]
15. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects.
Polak K; Petternel V; Luksch A; Krohn J; Findl O; Polska E; Schmetterer L
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2949-56. PubMed ID: 11687541
[TBL] [Abstract][Full Text] [Related]
16. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation.
Weiss R; Dufour S; Groszmann A; Petersen K; Dziura J; Taksali SE; Shulman G; Caprio S
J Clin Endocrinol Metab; 2003 May; 88(5):2014-8. PubMed ID: 12727947
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans.
Ahlborg G; Lindström J
J Appl Physiol (1985); 2002 Dec; 93(6):2112-21. PubMed ID: 12391119
[TBL] [Abstract][Full Text] [Related]
18. Insulin infusion reduces hepatocyte growth factor in lean humans.
de Courten B; de Courten MP; Dougherty S; Forbes JM; Potts JR; Considine RV
Metabolism; 2013 May; 62(5):647-50. PubMed ID: 23190875
[TBL] [Abstract][Full Text] [Related]
19. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
Hung YJ; Chen YC; Pei D; Kuo SW; Hsieh CH; Wu LY; He CT; Lee CH; Fan SC; Sheu WH
Diabet Med; 2005 Aug; 22(8):1024-30. PubMed ID: 16026368
[TBL] [Abstract][Full Text] [Related]
20. Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity.
Leonetti F; Iacobellis G; Ribaudo MC; Zappaterreno A; Tiberti C; Iannucci CV; Vecci E; Di Mario U
Regul Pept; 2004 Nov; 122(3):179-83. PubMed ID: 15491789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
